| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.81B | 55.74B | 52.99B | 54.77B | 46.36B | 38.40B |
| Gross Profit | 9.72B | 9.84B | 8.39B | 10.15B | 9.41B | 8.81B |
| EBITDA | 6.60B | 6.72B | 5.53B | 7.63B | 7.11B | 5.88B |
| Net Income | 2.20B | 2.42B | 1.87B | 2.99B | 2.85B | 1.93B |
Balance Sheet | ||||||
| Total Assets | 88.20B | 88.34B | 82.71B | 75.72B | 72.13B | 69.18B |
| Cash, Cash Equivalents and Short-Term Investments | 12.43B | 14.09B | 14.31B | 11.66B | 13.06B | 13.33B |
| Total Debt | 11.49B | 12.53B | 9.53B | 6.86B | 5.00B | 6.54B |
| Total Liabilities | 28.73B | 28.94B | 24.94B | 22.06B | 20.86B | 18.95B |
| Stockholders Equity | 58.93B | 58.84B | 57.29B | 53.22B | 50.90B | 49.89B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.28B | 1.36B | -2.11B | 2.37B | 96.00M |
| Operating Cash Flow | 0.00 | 5.06B | 4.98B | 581.00M | 4.84B | 4.95B |
| Investing Cash Flow | 0.00 | -7.08B | -3.95B | -2.98B | -2.81B | -4.91B |
| Financing Cash Flow | 0.00 | 1.68B | 1.45B | 825.00M | -2.36B | 2.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥50.64B | 10.10 | 9.07% | 4.46% | -1.14% | 34.15% | |
75 Outperform | ¥174.90B | 10.40 | ― | 3.50% | 3.85% | -1.53% | |
70 Outperform | ¥87.56B | 10.34 | ― | 3.74% | -0.68% | -9.93% | |
66 Neutral | ¥34.86B | 35.78 | ― | 3.24% | 1.83% | -8.54% | |
63 Neutral | ¥202.63B | 10.31 | 6.95% | 3.06% | -7.36% | -574.56% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥162.79B | 9.97 | 4.24% | 3.76% | -7.81% | 25.04% |